19451442Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Staehler M, Negrier S, Chevreau C, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Anderson S, Hofilena G, Shan M, Pena C, Lathia C, Bukowski RMJournal of clinical oncology : official journal of the American Society of Clinical OncologyBenzenesulfonates; Carcinoma, Renal Cell; Kidney Neoplasms; PyridinesAged; Antineoplastic Agents; Cross-Over Studies; Diarrhea; Disease-Free Survival; Double-Blind Method; Fatigue; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nausea; Niacinamide; Phenylurea Compounds; Prognosis; Sorafenib; Treatment Outcome; Vascular Endothelial Growth Factor ASorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. J Clin Oncol. 2009 Jul 10; 27(20):3312-8.J Clin Oncol2009-05-18T00:00:002009Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD002292Disorders1134250.717085Carcinoma, Renal CellD003967Disorders941810.900364DiarrheaD007680Disorders1406200.652811Kidney NeoplasmsD004311Procedures33818220.708936Double-Blind MethodD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD010671Chemicals & Drugs511130.945896Phenylurea CompoundsD009325Disorders551750.871982NauseaD005221Disorders1091740.909592FatigueD005260Physiology1992444050.191167FemaleD011725Chemicals & Drugs1533090.839039PyridinesD006801Living Beings2262862810.130052HumansAuthorship 381583D008297Physiology1931408600.201617Male0.08924370.08924371authors10.2523has subject areaD016896Concepts & Ideas101179490.402389Treatment OutcomeD018592Procedures1383990.901207Cross-Over StudiesD011379Procedures74536690.561447PrognosisD015999Concepts & Ideas4199970.796631Multivariate AnalysisD042461Chemicals & Drugs1564070.844293Vascular Endothelial Growth Factor AD053208Concepts & Ideas3258590.818599Kaplan-Meier EstimateD001557Chemicals & Drugs29660.952978BenzenesulfonatesD009536Chemicals & Drugs541160.957027NiacinamideD018572Concepts & Ideas25812030.792696Disease-Free SurvivalMedicineUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.Professortrue1ProfessorProfessor